Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical TrialRobin K. Avery, Francisco M. Marty, Aimee K. Sundberg et al.|Clinical Infectious Diseases|2021Cited by 299